StockNews.com downgraded shares of DaVita (NYSE:DVA – Free Report) from a buy rating to a hold rating in a report issued on Friday morning.
DVA has been the topic of a number of other research reports. Sanford C. Bernstein set a $184.00 price objective on DaVita in a report on Friday, February 21st. Cowen reiterated a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. Finally, Barclays lifted their price target on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, DaVita has an average rating of “Hold” and an average target price of $166.33.
View Our Latest Research Report on DVA
DaVita Price Performance
DaVita (NYSE:DVA – Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Research analysts anticipate that DaVita will post 10.76 earnings per share for the current year.
Institutional Investors Weigh In On DaVita
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Copia Wealth Management acquired a new position in shares of DaVita during the 4th quarter worth approximately $30,000. SBI Securities Co. Ltd. acquired a new position in shares of DaVita during the 4th quarter worth approximately $41,000. Coppell Advisory Solutions LLC raised its position in shares of DaVita by 50.0% during the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company’s stock worth $45,000 after purchasing an additional 100 shares during the last quarter. Quarry LP acquired a new position in shares of DaVita during the 3rd quarter worth approximately $60,000. Finally, Canada Post Corp Registered Pension Plan acquired a new position in shares of DaVita during the 4th quarter worth approximately $55,000. 90.12% of the stock is currently owned by institutional investors and hedge funds.
About DaVita
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Read More
- Five stocks we like better than DaVita
- What Are Trending Stocks? Trending Stocks Explained
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Stock Market Upgrades: What Are They?
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Insider Buying Explained: What Investors Need to Know
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.